Yahoo
TSXV - Delayed Quote CAD

Sharp Therapeutics Corp. (SHRX.V)

1.3700 0.0000 (0.00%)
At close: September 21 at 11:31:12 AM EDT
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
Total Revenue
0
0
0
0
Operating Expense
5,541.9910
5,512.5510
4,551.6130
2,267.5420
Operating Income
-5,541.9910
-5,512.5510
-4,551.6130
-2,267.5420
Net Non Operating Interest Income Expense
-164.0090
-166.8090
-170.9510
-174.4750
Other Income Expense
525.1690
-494.6720
1,461.9240
-1,122.7300
Pretax Income
-5,180.8310
-6,174.0320
-3,260.6400
-3,564.7470
Net Income Common Stockholders
-5,180.8310
-6,174.0320
-3,260.6400
-3,564.7470
Diluted NI Available to Com Stockholders
-5,180.8310
-6,174.0320
-3,260.6400
-3,564.7470
Basic EPS
-0.17
-0.21
-0.36
-0.13
Diluted EPS
-0.17
-0.21
-0.36
-0.13
Basic Average Shares
30,054.1840
29,457.0270
8,998.2300
28,220.8480
Diluted Average Shares
30,054.1840
29,457.0270
8,998.2300
28,220.8480
Total Operating Income as Reported
-5,541.9910
-5,512.5510
-2,540.7350
2,267.5420
Total Expenses
5,541.9910
5,512.5510
4,551.6130
2,267.5420
Net Income from Continuing & Discontinued Operation
-5,180.8310
-6,174.0320
-3,260.6400
-3,564.7470
Normalized Income
-5,724.6810
-5,648.9080
-5,017.6300
-2,439.4310
Interest Income
0.1130
0.0820
0
--
Interest Expense
164.1220
166.8910
170.9510
174.4750
Net Interest Income
-164.0090
-166.8090
-170.9510
-174.4750
EBIT
-5,016.7090
-6,007.1410
-3,089.6890
-3,390.2720
EBITDA
-4,924.0210
-5,908.8260
-2,989.3940
-3,275.8520
Reconciled Depreciation
92.6880
98.3150
100.2950
114.4200
Net Income from Continuing Operation Net Minority Interest
-5,180.8310
-6,174.0320
-3,260.6400
-3,564.7470
Total Unusual Items Excluding Goodwill
543.8500
-525.1240
1,756.9900
-1,125.3160
Total Unusual Items
543.8500
-525.1240
1,756.9900
-1,125.3160
Normalized EBITDA
-5,467.8710
-5,383.7020
-4,746.3840
-2,150.5360
Tax Rate for Calcs
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
12/31/2023 - 1/17/2025

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: